Table 4.

Clavien-Dindo classification of long-term complications

Complication	N = 36	Action
Clavien I
Persistence of voiding dysfunction	2 (3.8%)	Observation
Clavien II
De novo OAB	15 (41.6%)	Antimuscarinics/β-agonists
Recurrent UTIs	2 (3.8%)	Antimicrobial prophylaxis or therapy

Data are expressed as an absolute number (%)